Details of the Drug

General Information of Drug (ID: DM0ILOX)

• Drug Name: SPN-810
• Synonyms: Molindone hydrochloride; 15622-65-8; Molindone HCl; Lidone; Molindone (hydrochloride); EN-1733A; EN 1733 A; EN300-51039; 3-Ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-4H-indol-4-one hydrochloride; Indol-4(5H)-one, 3-ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)-, monohydrochloride; DSSTox_RID_80866; DSSTox_CID_25417; DSSTox_GSID_45417; 3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-4,5,6,7-tetrahydro-1H-indol-4-one hydrochloride; SMR000499578; 3-Ethyl-6,7-dihydro-2-methyl-5-morpholinomethylindo

Indication

Disease Entry	ICD 11	Status	REF
Attention deficit hyperactivity disorder	6A05.Z	Phase 3	[1]

• Chemical Identifiers:
  Formula: C16H25ClN2O2
  Canonical SMILES: CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C.Cl
  InChI: InChI=1S/C16H24N2O2.ClH/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18;/h12,17H,3-10H2,1-2H3;1H
  InChIKey: GQWNECFJGBQMBO-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 9883259
  ChEBI ID: CHEMBL6966
  CAS Number: 15622-65-8
  TTD ID: D03AJF
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)